Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Pfizer and Voyager Therapeutics, a Cambridge, Massachusetts company developing gene therapies, have entered into a licensing agreement under which Pfizer may exercise options to license capsids generated from Voyager’s screening technology to...

Moderna has announced plans to build a new $500-million mRNA vaccine production facility in Africa for its COVID-19 vaccine and its other vaccine candidates with the goal of producing up to 500 million doses of vaccines each year at a 50-µg dose...

Merck & Co. has agreed to acquire Acceleron Pharma, a Cambridge, Massachusetts-based bio/pharmaceutical company, for an approximate total equity value of $11.5 billion. Acceleron focuses on using the transforming growth factor (TGF)-beta...